![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)
Provectus Pharmaceuticals Inc. (PVCT.OB) Adds Second Site for Phase 2 Clinical Study of PH-10 for Psoriasis
QualityStocks (August 18th, 2009) Writes:
Provectus Pharmaceuticals Inc. is quickly gaining a reputation as an up-and-coming development-stage oncology and dermatology biopharmaceutical company. Helping to enhance this reputation and its position in the marketplace, Provectus announced the addition of Mount Sinai School of Medicine as the second and final site for its expanded Phase 2 clinical trial of the company’s lead dermatology agent PH-10 for psoriasis. Jason Elmer, M.D., who served as the lead investigator for the Phase 2 clinical trial of PH-10 for atopic dermatitis of which patent enrollment was completed in June, will also serve as the principal investigator of this trial.
Commenting on the value of Dr. Elmer’s work on this project, Provectus CEO Craig Dees, Ph.D. stated, “Dr. Emer’s work with PH-10 for atopic dermatitis, his involvement in the ongoing research of the product as a dermatological therapy, and Mount Sinai School of Medicine’s outstanding reputation in dermatological research make this
...Atopic Dermatitis, ceo, Craig Dees, dermatology biopharmaceutical, Emer, final site, Jason Elmer, lead investigator, Market Commentary, Mount Sinai School of Medicine;, National Institute of Health, National Psoriasis Foundation, PH, PH-10, principal investigator, Provectus Pharmaceuticals Inc., psoriasis, Skin Disorders, Small & Micro Cap, Telex (PH-10) Headset, treatment of cutaneous skin disorders, United States, USD, www.clinicaltrials.gov, www.pvct.com
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.